The effects of a leukocyte-depleting filter on cerebral and renal recovery after deep hypothermic circulatory arrest  by Langley, Stephen M. et al.
A lthough neutrophils were first seen in human cere-bral infarcts over 10 years ago,1,2 it is only recently
that their contribution to reperfusion brain injury has
been appreciated. Neutrophils are usually the first
exogenous cells to infiltrate the ischemic brain. They
contribute to the development of ischemia by increasing
capillary plugging, reducing cerebromicrovascular
blood flow, and increasing vascular permeability.3,4 In
addition, neutrophils infiltrate the brain parenchyma
and damage neurons and glial cells. Neutrophil secre-
Objective: The purpose of this study was to determine the effects of a leuko-
cyte-depleting filter on cerebral and renal recovery after deep hypothermic
circulatory arrest. 
Methods: Sixteen 1-week-old piglets underwent cardiopulmonary bypass,
were cooled to 18˚C, and underwent 60 minutes of circulatory arrest, fol-
lowed by 60 minutes of reperfusion and rewarming. Global and regional
cerebral blood flow, cerebral oxygen metabolism, and renal blood flow were
determined before cardiopulmonary bypass, after the institution of car-
diopulmonary bypass, and at 1 hour of deep hypothermic circulatory arrest.
In the study group (n = 8 piglets), a leukocyte-depleting arterial blood filter
was placed in the arterial side of the cardiopulmonary bypass circuit. 
Results: With cardiopulmonary bypass, no detectable change occurred in the
cerebral blood flow, cerebral oxygen metabolism, and renal blood flow in
either group, compared with before cardiopulmonary bypass. In control ani-
mals, after deep hypothermic circulatory arrest, blood flow was reduced to all
regions of the brain (P < .004) and the kidneys (P = .02), compared with before
deep hypothermic circulatory arrest. Cerebral oxygen metabolism was also
significantly reduced to 60.1% ± 11.3% of the value before deep hypothermic
circulatory arrest (P = .001). In the leukocyte-depleting filter group, the region-
al cerebral blood flow after deep hypothermic circulatory arrest was reduced,
compared with the value before deep hypothermic circulatory arrest (P < .01).
Percentage recovery of cerebral blood flow was higher in the leukocyte filter
group than in the control animals in all regions but not significantly so (P > .1).
The cerebral oxygen metabolism fell to 66.0% ± 22.3% of the level before
deep hypothermic circulatory arrest, which was greater than the recovery in the
control animals but not significantly so (P = .5). After deep hypothermic cir-
culatory arrest, the renal blood flow fell to 81.0% ± 29.5% of the value before
deep hypothermic circulatory arrest (P = .06). Improvement in renal blood
flow in the leukocyte filter group was not significantly greater than the recov-
ery to 70.2% ± 26.3% in control animals (P = .47). 
Conclusions: After a period of deep hypothermic circulatory arrest, there is
a significant reduction in cerebral blood flow, cerebral oxygen metabolism,
and renal blood flow. Leukocyte depletion with an in-line arterial filter does
not appear to significantly improve these findings in the neonatal piglet. 
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tion of oxygen-derived free radicals, cytokines, pro-
teases, and lipid-derived mediators such as arachidonic
acid and leukotrienes contributes to the cerebral injury
that results from a period of cerebral ischemia and
reperfusion. 
The importance of neutrophils in cerebral ischemic
damage began to emerge after studies in the early
1990s, which showed a reduction in neuronal injury
after ischemia in neutropenic animals. Immuno-
depletion of neutrophils can reduce the cerebral infarct
size after middle cerebral artery occlusion.5,6 In addi-
tion, neutropenia, which is caused by monoclonal anti-
neutrophil serum, results in significantly reduced cere-
bral edema after cerebral ischemia.6,7 Other studies
have shown improved cerebral blood flow (CBF) and
reduced neurologic deficit with neutropenia.5
A variety of different leukocyte-depleting blood fil-
ters have been used in various experimental models
in an attempt to modulate the effects of activated
leukocytes after cardiopulmonary bypass (CPB). One
such leukocyte-depleting filter is the LeukoGuard 6
(LG6; Pall Biomedical Products Corporation, East
Hills, NY). The LG6 filter consists of a 40-µm screen
filter for removal of microaggregates and an
autoventing gross and micro air-separating chamber.
In addition it contains a depth filter of nonwoven
polyester fiber to remove leukocytes. Previous stud-
ies with the LG6 filter (with bovine blood) have
shown a 50% total leukocyte reduction and a 70%
neutrophil depletion rate over a 90-minute perfusion
period with both pulsatile8 and nonpulsatile9 perfu-
sion. In another study during 1 hour of simulated
CPB, the mean reduction in white cell count across
the filter was 45%, and the reduction of neutrophils
was 70%. Furthermore, the filter diminished the aver-
age expression of cellular markers for neutrophil
activation (ie, CD11b, CD45Ro, CD67, and L-
selectin) by approximately 20% after 1 hour of CPB,
compared with the control animals.10
There are no previously reported studies in which
markers of acute cerebral impairment have been used
to investigate the effects of leukocyte depletion during
CPB. It is now well established that neutrophils con-
tribute to injury that results from cerebral ischemia.
The aim of the current study was to determine the
effects of an LG6 filter on cerebral and renal recovery
after deep hypothermic circulatory arrest (DHCA). The
null hypothesis for this study is that incorporation of an
in-line LG6 filter in the arterial side of the CPB circuit
does not affect CBF and metabolism or renal blood
flow (RBF) after 60 minutes of DHCA in the neonatal
piglet.
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Methods
Animal preparation. All animal experiments were con-
ducted with the approval of the institution’s Animal Care and
Use Committee. The animals received humane care in com-
pliance with the “Guide for the Care and Use of Laboratory
Animals” published by the National Institutes of Health (NIH
publication 85-23, revised 1995) and were housed in the
institution’s NIH-approved animal facility before the experi-
ments. 
Sixteen neonatal piglets (aged, 1-2 weeks; weight, 2.3 ±
0.1 kg [mean ± SEM]) were anesthetized with an intramus-
cular injection of ketamine (50 mg · kg–1) and acepromazine
(15 µg · kg–1). Intravenous methylprednisolone (30 mg · kg–1)
was administered through a 24-gauge cannula in the margin-
al vein of the pinna. Orotracheal intubation was performed,
and mechanical ventilation (Infant Ventilator; Sechrist
Industries, Anaheim, Calif) was commenced to achieve arte-
rial oxygen tensions of 150 to 250 mm Hg and carbon diox-
ide tensions of 35 to 45 mm Hg. The animals were paralyzed
with intravenous pancuronium (300 µg · kg–1) and anes-
thetized with fentanyl (100 µg · kg–1). Thereafter, anesthesia
was maintained with a continuous infusion of fentanyl (25 µg
· kg–1 · h–1). An 18-gauge cannula was placed in the descend-
ing aorta through the femoral artery for blood pressure mon-
itoring and arterial blood sampling. The animal’s temperature
was monitored throughout the study by an indwelling
nasopharyngeal temperature probe (Yellow Springs
Instrument Co, Inc, Yellow Springs, Ohio). Temperature was
maintained at 36˚C, except for the period of induced
hypothermia. The heart was exposed through a median ster-
notomy. Cardiac instrumentation consisted of the insertion of
a 3F micromanometer (Millar Instruments Inc, Houston, Tex)
into the superior vena cava for central venous pressure mon-
itoring, the insertion of a 22-gauge plastic catheter into the
left atrium through the left atrial appendage, and the place-
ment of an 8-mm flow probe (Transonic Systems, Ithaca,
NY) around the proximal pulmonary artery for cardiac output
monitoring.
Sagittal sinus access. The animals were anticoagulated
with intravenous heparin (500 IU/kg) before the sagittal sinus
was accessed. A 1-cm strip of scalp was raised in the midline
over the vertex of the skull. Two separate 2-mm burr holes
were made over the superior sagittal sinus for repeated sagit-
tal sinus venous blood sampling and continuous sagittal sinus
venous pressure monitoring with a 3F micromanometer
(Millar Instruments Inc).
CPB and circulatory arrest. An 8F arterial cannula and a
20F venous cannula (DLP Inc, Grand Rapids, Mich) were
inserted through purse-string sutures into the ascending aorta
and the right atrium, respectively. CPB was commenced at a
flow rate of 120 mL · kg–1 · min–1. The pump-oxygenator sys-
tem consisted of a nonpulsatile roller pump (Sarns/3M, Ann
Arbor, Mich) and a hollow-fiber membrane oxygenator
(Medtronic Minimax PLUS; Medtronic Inc, Anaheim, Calif).
The circuit was primed with heparinized fresh blood from a
donor pig. Ringer lactate and sodium bicarbonate solutions
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were added to the prime to achieve a hematocrit value of 0.25
and a pH of 7.4 at 37˚C. The total prime volume was approx-
imately 450 mL. The temperature of the perfusate was con-
trolled with the integral heat exchanger in the venous reser-
voir of the oxygenator and a water bath system (BIO-CAL
370; Medtronic Bio-Medicus, Minneapolis, Minn). Animals
were cooled to a temperature of 18˚C over a standard dura-
tion of 20 minutes by the circulation of ice water through the
heat exchanger. At the end of the cooling period, the circula-
tion was arrested, and the animal was drained. DHCA was
established, and the aortic and right atrial cannulas were
clamped. After 60 minutes of DHCA, the aortic and venous
cannulas were unclamped. Perfusion was re-established at
120 mL · kg–1 · min–1, with the perfusate initially at room
temperature (20˚C-22˚C). Rewarming was accomplished by
circulating warm water to the heat exchanger in the venous
reservoir. A nasopharyngeal temperature of 36˚C was gener-
ally reached by 45 minutes of reperfusion. During cooling
and rewarming, blood gases were managed according to the
alpha-stat strategy. The arterial pH was maintained at 7.35 to
7.45, and carbon dioxide tension was maintained at 35 to 45
mm Hg, measured at 37˚C and uncorrected for the tempera-
ture of the animal. Arterial oxygen tension was kept between
150 and 250 mm Hg, and hematocrit level was kept between
0.23 and 0.28. Sodium bicarbonate (8.4%) was given when
necessary but not immediately before CBF measurements. At
the end of the study, the animals were killed by a bolus injec-
tion of fentanyl and cessation of CPB.
Measurement of CBF. CBF measurements were deter-
mined by the reference-sample, radiolabeled microsphere
technique11 during CPB at 36˚C. The technique described in
the current study is similar to that used in previous reports
from our laboratory.12,13 Suspensions of microspheres with a
diameter of 15.5 ± 0.1 µm (DuPont de Nemours & Co,
Wilmington, Del) were made up in 10% dextran and 0.01%
polysorbate 80 (TWEEN 80; ICI Americas Inc, Wilmington,
Del) with 106 microspheres per milliliter. Three different iso-
topes were used in each piglet (46Sc, 103Ru, and 95Nb). For
each flow measurement, 106 microspheres were injected into
a side port of the arterial tubing 30 cm proximal to the aor-
tic cannula over 30 seconds and washed through with 5 mL
warm saline solution. A reference blood sample was with-
drawn from the distal aorta at a constant rate of 3 mL · min–1
with a Harvard syringe pump (Harvard Apparatus, South
Natick, Mass), commencing 10 seconds before the micros-
phere injection and continued for a total of 2 minutes. At the
end of the experiment, the brain was removed and divided
into left and right cerebral hemispheres, basal ganglia, cere-
bellum, and brain stem (midbrain, pons, and medulla oblon-
gata). In addition, the kidneys were also removed for a deter-
mination of RBF. After measurement of fresh weights, the
brain parts and kidneys were dissolved in 2 mol/L potassium
hydroxide solution and analyzed, together with the reference
blood sample, in a gamma counter (Auto-Gamma 5530;
Packard Instrument Co, Meriden, Conn) to estimate the
quantity of each type of radiolabeled microsphere present in
the specimen. The withdrawal rate of the reference blood
sample and the ratio of counts from a brain part to the refer-
ence blood sample allowed calculation of regional CBF.
CBF measurements are expressed in milliliters per 100
grams of brain per minute by normalizing for fresh tissue
weight. The weighted sum of regional CBF allowed calcula-
tion of global CBF. 
Cerebral perfusion pressure was taken as the difference
between the mean arterial pressure and the sagittal sinus
venous pressure. Cerebral vascular resistance (CVR) was the
ratio of cerebral perfusion pressure to global CBF (in units of
millimeters of mercury · 100 gm · min · mL–1). Systemic vas-
cular resistance was taken as the ratio between the systemic
perfusion pressure and the total bypass pump flow rate (sys-
temic vascular resistance = [mean arterial pressure – right
atrial pressure]/[pump flow rate] in units of millimeters of
mercury · 100 gm · min · mL-1). 
Measurement of cerebral oxygen handling. Arterial and
sagittal sinus blood samples were taken just before each
microsphere injection for estimation of oxygen tension, car-
bon dioxide tension, oxygen saturation, pH, and base excess
with a GEM-Stat Blood Gas/Electrolyte Monitor (Mallin-
ckrodt Sensor Systems Inc, Ann Arbor, Mich). Hemoglobin
levels (in grams per deciliter) were measured from arterial
blood samples (482 Co-Oximeter; Instrumentation Laboratory
Corp, Lexington, Mass). Cerebral delivery of oxygen (CDO2,
in milliliters per 100 g of brain per minute), cerebral metabol-
ic rate of oxygen (CMRO2, in milliliters per 100 g of brain per
minute), and cerebral oxygen extraction (CEO2, as a percent)
were calculated as follows: CDO2 = CBF × arterial oxygen
content; CMRO2 = CBF × (arterial oxygen content – sagittal
sinus venous oxygen content); and CEO2 = (CMRO2/CDO2) ×
100%. The oxygen content (in units of milliliters of oxygen
per milliliter of blood) was calculated by the following for-
mula: oxygen content = 0.01 × [(1.36)(hemoglobin)(oxygen
saturation) + (0.003)(oxygen tension)].
Experimental protocol and data collection. The animals
were randomized into 2 groups, with 8 animals in each group.
In the study group an LG6 leukocyte depletion arterial blood
filter was placed in the arterial side of the CPB circuit before
priming. The filter was sited distal to the membrane oxy-
genator and about 5 feet proximal to the aortic cannula. The
control group underwent CPB without the use of a leukocyte-
depleting filter in the bypass circuit. In control animals an
AutoVent-6 screen filter (Pall Biomedical Products
Corporation) was used. This filter differs from the LG6 filter
in that the depth filter of nonwoven polyester fiber for leuko-
cyte removal is absent. All animals were cannulated for CPB,
and at 20 minutes after the end of instrumentation, micro-
spheres were injected through the left atrial catheter for the
CBF measurement before CPB. After the collection of the
reference blood sample, normothermic perfusion was com-
menced at 120 mL · kg–1 · min–1. Once the animals were sta-
bilized, the pump flow rate was adjusted to provide and main-
tain a constant cerebral perfusion pressure of 50 mm Hg for
15 minutes. The measurement before DHCA was performed;
the pump flow rate was returned to 120 mg · kg–1 · min–1, and
the mean arterial pressure was allowed to drift. All the ani-
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mals were cooled to a nasopharyngeal temperature of 16˚C to
18˚C over 20 minutes. The circulation was arrested, and the
animal was drained. After 60 minutes of DHCA, circulation
was recommenced at 120 mg · kg–1 · min–1, and the animal
was rewarmed. After 45 minutes of rewarming, the pump
flow rate was again adjusted to maintain a cerebral perfusion
pressure of 50 mm Hg. When the animal had been rewarmed
for a total of 60 minutes, the third CBF measurement was per-
formed. Data collected at the 2 time points included nasopha-
ryngeal temperature, mean arterial pressure, right atrial pres-
sure, sagittal sinus venous pressure, arterial and sagittal sinus
blood gases, CPB flow rate, electrolytes, hematocrit, hemo-
globin, CBF, and RBF. 
Statistical analysis. All results are reported as mean ± SD.
The results were entered into a Microsoft Excel 97 spreadsheet
(Microsoft Corporation, Redmond, Wash) for further analysis.
Repeating formulae calculated the mean and SEM for all data
collected in each animal. Further repeating formulae were pro-
grammed for calculation of the CBF, CDO2, CEO2, CMRO2
and the percentage change between these, before CPB and
before and after DHCA in each animal. A repeated measures
multivariate analysis of variance (MANOVA; SAS 6.12TS045;
SAS Institute, Inc, Cary, NC) was used to compare variable
means within each group. When the Wilks’ Lambda statistic
resulted in a probability value of less than .05, multiple paired
comparisons were made with a paired samples t test to better
identify the source of the difference. A factorial model analysis
of variance was used to compare percentage reductions of blood
flow to different brain regions after DHCA. Individual compar-
isons between regional means were performed with an unpaired
(independent samples) t test. An unpaired t test was also used to
compare variable means between the groups and to compare
relative (percent) change in CBF, CDO2, and CMRO2.
Results
Before CPB, regional and global CBF, CVR, cerebral
oxygen handling, and RBF were similar in both the
control and the LG6 groups (independent samples t
test; P > .18). No significant differences were detected
between the 2 groups in cerebral perfusion pressure,
nasopharyngeal temperature, arterial blood gases, pH,
hematocrit and hemoglobin at each measurement (inde-
pendent samples t test; P > .10, data not shown). Within
each group, no significant differences were detected in
cerebral perfusion pressure, nasopharyngeal tempera-
ture, arterial blood gases, and pH at all 3 time points
(MANOVA; P > .11).
Effects of CPB. At the commencement of CPB the
right atrial pressure in the control group fell from 2.3 ±
0.7 mm Hg to 0.2 ± 0.1 mm Hg (P = .0001). A similar
drop occurred in the LG6 filter group. The systemic
vascular resistance did not change significantly in
either group, and the pump flow was not significantly
different from the pre-CPB cardiac output. In the con-
trol group, the hemoglobin level fell from 11.1 ± 0.8
g/dL to 8.9 ± 0.7 g/dL (P = .0002), and the hematocrit
level fell from 33.1% ± 2.1% to 27.5% ± 2.4% (P =
.002) at the onset of CPB. Similar drops developed in
the LG6 filter group. No significant difference in glob-
al or regional CBF, CMRO2, CVR, or RBF was detect-
ed in either group at the onset of CPB compared with
the pre-CPB values (P > .06). Furthermore, no differ-
ence in these variables was detected between the
groups (P > .29).
Effects of DHCA on the brain. Sixty minutes of
DHCA followed by 60 minutes of rewarming in the
control group resulted in a significant fall in the sys-
temic vascular resistance from 0.46 ± 0.09 mm Hg ·100
gm · min · mL–1 before DHCA to 0.35 ± 0.05 mm Hg ·
100 gm · min · mL–1 after DHCA (P = .01). As a result
of this, the pump flow was increased from 131 ± 24 to
168 ± 22 mL · kg–1 · min–1 (P = .01) to maintain the
preset cerebral perfusion pressure of 50 mm Hg at the
time of CBF measurement. The sagittal sinus oxygen
tension fell from 27.1 ± 2.5 mm Hg to 23.3 ± 1.6 mm
Hg, and the sagittal sinus oxygen saturation fell from
42.7% ± 6.5% to 26.0% ± 5.5%. These values were sig-
nificantly lower than the levels before both CPB and
DHCA (P < .02). The sagittal sinus carbon dioxide ten-
sion increased after DHCA from 63.6 ± 9.7 mm Hg to
76.8 ± 14.7 mm Hg (P = .02), and the pH fell from 7.29
± 0.02 to 7.26 ± 0.04 (P = .05). 
There was a significant reduction in blood flow to all
regions of the brain in the control group after DHCA (P
< .004; Table I). Different brain regions were affected
to different degrees. Recovery of blood flow was low-
est in the cerebral hemispheres (39.4% ± 17.5% of pre-
DHCA level) and greatest in the brain stem (65.5% ±
8.0%; P < .05; Fig 1). The CVR rose significantly after
DHCA (P = .00003). The CDO2 and CMRO2 both fell
to 47.7% ± 12.6% and 60.1% ± 11.3% of the pre-
DHCA levels, respectively (P = .001), and the CEO2
was significantly higher after DHCA (P = .001; Table
II). RBF was significantly lower after DHCA, falling to
70.2% ± 26.3% of the flow before DHCA (P = .02).
Effects of a leukocyte-depleting filter. A similar
pattern was seen in the LG6 filter group as in the con-
trol group in that 60 minutes of DHCA resulted in a fall
in the systemic vascular resistance (P = .02), with the
need to increase the pump flow to maintain the cerebral
perfusion pressure at 50 mm Hg. The sagittal sinus
oxygen saturation fell from 38.4% ± 5.3% to 27.4% ±
7.2% (P = .04), and the sagittal sinus carbon dioxide
tension rose from 58.1 ± 8.4 mm Hg to 67.4 ± 5.0 mm
Hg (P = .01). There was no significant difference after
DHCA, however, in either sagittal sinus oxygen tension
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Fig 2. Mean cerebrovascular resistance in control and LG6
filter groups before CPB and before and after DHCA. Pre-
DHCA, After commencement of CPB but before DHCA;
Post-DHCA, after 60 minutes of DHCA at 18˚C and 60 min-
utes of rewarming. *Significant difference from pre-CPB
value within group; P < .05. †Significant difference from pre-
DHCA value within group; P < .05.
(P = .09) or sagittal sinus pH (P = .13) compared with
the pre-DHCA values. 
There was also a significant reduction in CBF to all
brain regions after DHCA, compared with the pre-
DHCA value (P < .01). The percentage recovery of
CBF in the LG6 group was higher than in the control
group after DHCA in all regions, but the difference did
not reach significance (P > .01; Fig 1). In the brain
stem, however, no statistically significant difference
was detected in CBF after DHCA when compared with
the value before bypass (P = .07). After DHCA in the
LG6 filter group, the CVR was higher than the level
before DHCA (P = .001). The increase in CVR after
DHCA was less than in the control animals, but the dif-
ference between the 2 groups did not reach significance
(Fig 2). Although the fall in absolute CDO2 was less in
the filter group than the control group and the percent-
age recovery in CDO2 to 55.2% ± 13.0% of the pre-
DHCA level was greater, neither difference reached
statistical significance. The CMRO2 was also signifi-
cantly lower after DHCA (P = .01), falling to 66.0% ±
22.3% of the pre-DHCA level. As with the CDO2,
although the fall in absolute CMRO2 was less and the
percentage recovery in CMRO2 was greater than the
control group, neither difference reached significance.
After DHCA, the RBF in the LG6 group fell to 81.0%
± 29.5% of the pre-DHCA value (P = .06). Although
there was no significant difference in RBF at any time
point in the LG6 group, the improvement in RBF in the
leukocyte filter group after DHCA was not significant-
ly greater than the recovery to 70.2% ± 26.3% in con-
trol animals (P = .47). 
Discussion
Cerebral ischemia is accompanied by an acute
inflammatory response characterized by leukocyte
infiltration and development of brain edema.4,14 It is
now well established that neutrophils accumulate in
the brain after both focal5,6 and global15,16 ischemia
and that the increase in neutrophils is associated with
neurologic damage. Neutrophils have been identified
in microvessels as early as 30 minutes after the onset
of ischemia, and the number of intravascular neu-
trophils seems to peak at about 12 hours.17
Parenchymal infiltration occurs slightly later but has
been shown to begin as early as 6 hours after reper-
fusion, peaking at 24 to 48 hours.18 The early appear-
ance of luminal leukocytes in ischemia suggests that
these cells contribute to the genesis of ischemia-
reperfusion injury.
The current study shows that the establishment of
normothermic CPB in the neonatal piglet is well toler-
ated and does not result in significant changes in cere-
bral hemodynamics. The significant drop in right atrial
pressure at the onset of CPB indicates good venous
drainage from the heart to the venous reservoir of the
CPB circuit. The fall in hemoglobin and hematocrit
levels is due to hemodilution caused by crystalloid in
the CPB priming fluid. Both the control and the LG6
filter group showed a similar response to the com-
Fig 1. Global and regional CBF at 1 hour of reperfusion after
60 minutes of DHCA at 18˚C in control and LG6 filter
groups. Data are expressed as percentage of baseline CBF
before DHCA. HEMI, Cerebral hemispheres; CBLM, cere-
bellum; BG, basal ganglia; BS, brain stem. *No significant
difference between CBF before CPB and after DHCA within
the group. 
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mencement of CPB. There were no significant changes
between the 2 groups before DHCA. 
After 60 minutes of DHCA at 18˚C and 60 minutes of
rewarming in the control group, the systemic vascular
resistance level fell, and the pump flow was increased to
maintain a constant cerebral perfusion pressure. The drop
in the sagittal sinus oxygen tension, sagittal sinus oxygen
saturation, and sagittal sinus pH and the rise in sagittal
sinus carbon dioxide tension after DHCA reflect the
increased oxygen extraction and the buildup of metabo-
lites of anaerobic metabolism during ischemia. A drop in
blood flow to all regions of the brain and to the kidneys
followed DHCA. There was regional variation in CBF,
however, with percentage recovery from the pre-DHCA
level being greatest in the brain stem and lowest in the
cerebral hemispheres. Because the arterial oxygen con-
tent was maintained at a constant level, the reduction in
CBF was primarily responsible for the drop in CDO2.
The combination of reduced CBF and increased CEO2
accounts for the fall in the CMRO2. 
In the LG6 filter group, the pattern was similar to that
in the control animals. The period of ischemia caused
the drop in sagittal sinus oxygen saturation and the rise
in sagittal sinus carbon dioxide tension after DHCA. In
contrast with the control group, there was no significant
difference in either sagittal sinus oxygen tension or
sagittal sinus pH after DHCA; however, the CEO2 was
still significantly higher than before DHCA. Inter-
pretation of these results is not easy; it would seem that
a trend toward improved recovery of sagittal sinus
blood gases is present in the LG6 group compared with
the control group. In the LG6 filter group, all the sagit-
tal sinus blood gas variables are less impaired than in
the control group after DHCA; however, the sagittal
sinus oxygen tension and the sagittal sinus pH were the
only variables not significantly impaired by compari-
son with the control group. 
The CBF after DHCA in the LG6 group was signifi-
cantly lower than the pre-DHCA value in all regions. It
was also lower than the pre-CPB value in all regions
except the brain stem, where the difference was not
quite significant (P = .07). The results may suggest a
trend in the LG6 filter group toward greater recovery of
regional and global CBF compared with the control
group; the absolute values were higher than those in the
control group in all regions, and the difference
approached significance in the brain stem (P = .08) and
the basal ganglia (P = .07). The percentage recovery
from the pre-DHCA level was also higher in all brain
regions but did not reach statistical significance.
Although it is possible that a larger sample may result
in a more convincing improvement in CBF after
DHCA, the current study in the neonatal piglet does
not really demonstrate any meaningful benefit. As in
the control group, the CDO2 and CMRO2 were signif-
icantly lower and the CVR was significantly higher
than the value before DHCA. Again, both the absolute
and the relative differences were less in the LG6
group than the control group, but the differences did
not reach statistical significance. 
An improvement in CBF after cerebral ischemia has
been demonstrated in studies in which neutrophil-
endothelial adhesion processes are disturbed. Im-
munodepletion of neutrophils or the use of ICAM-1
deficient mice in cerebral ischemia-reperfusion results
in improved cortical CBF.5 After the use of monoclonal
antibody to the leukocyte integrin CD18 in an imma-
ture piglet model of DHCA, improved regional blood
flow to the brain stem, basal ganglia, and midbrain was
shown early during reperfusion, but not later.19
Table I. Global and regional CBF and RBF in control and LG6 filter groups before CPB and before and after
DHCA
Location Group Pre-CPB Pre-DHCA Post-DHCA
Global CBF Control 54.9 ± 16.1 48.9 ± 17.7 21.9 ± 8.7*†
LG6 filter 47.0 ± 11.6 50.6 ± 15.1 27.3 ± 11.3*†
Hemispheres Control 42.1 ± 12.1 48.7 ± 13.7 18.3 ± 7.9*†
LG6 filter 5.3 ± 13.6 41.5 ± 12.6 21.7 ± 9.8*†
Cerebellum Control 48.4 ± 13.4 52.8 ± 10.1 31.5 ± 7.6*†
LG6 filter 53.4 ± 13.1 47.3 ± 8.6 37.1 ± 5.9*†
Basal ganglia Control 50.8 ± 12.0 43.7 ± 10.4 24.5 ± 7.5*†
LG6 filter 43.0 ± 10.9 47.8 ± 11.8 31.6 ± 7.2*†
Brain stem Control 46.1 ± 11.8 42.4 ± 6.4 27.5 ± 5.1*†
LG6 filter 39.0 ± 7.9 46.7 ± 10.7 31.9 ± 5.2†
Renal Control 144.5 ± 33.3 146.6 ± 33.9 103.6 ± 20.5*†
LG6 filter 141.7 ± 30.3 146.1 ± 34.7 108.3 ± 25.2
All values in units of milliliters · 100 g–1 · min–1.
*Significant difference from pre-CPB value within group (MANOVA, P < .05).
†Significant difference from pre-DHCA value within group (MANOVA, P < .05)
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Whether adhesion of neutrophils represents a true hin-
drance to microvascular flow and thereby a reduction
of CBF during cerebral ischemia-reperfusion injury
remains uncertain.20
Statistically there was no significant difference at any
time point in RBF in the leukocyte depletion group.
When expressed as a percentage of the pre-DHCA
value, however, the improvement in RBF in the leuko-
cyte filter group after DHCA was not significantly
greater than the recovery in control animals. A clinical-
ly significant benefit would therefore seem unlikely.
Clinical evaluation of the LG6 filter has produced
somewhat mixed results. Although some studies have
concluded that leukocyte depletion should be used rou-
tinely in all children who undergo operations for cya-
notic heart disease or extracorporeal membrane oxy-
genation,21 others have concluded no benefit.22,23 The
potential benefits of leukocyte depletion do not only
apply to the brain. The heart, lungs, and gut are all sus-
ceptible to ischemia-reperfusion injury that is mediated
by activated neutrophils. Experiments suggest that
mechanical leukocyte filtration may be advantageous
in all these organs. With regard to post-CPB pulmonary
function, a number of beneficial effects of leukocyte
depletion have been reported. These include a reduc-
tion in ventilation time (and time in the intensive care
unit),24 improved oxygenation,25 and reduced pul-
monary edema and pulmonary vascular resistance.26
In a porcine model of neonatal cardiac surgery,
mechanical leukocyte depletion significantly reduced
the granulocyte count. This was associated with a
reduction in leukocyte sequestration in the coronary
vascular bed and a decrease in myocardial creatine
kinase release and with improved postischemic recov-
ery of left ventricular systolic function.27 Leukocyte
depletion has also been shown to reduce the severity of
reperfusion injury in the human small intestine.28
In conclusion, although the results with respect to all
the CBF and metabolism variables measured were con-
sistently better in the LG6 filter group than in the con-
trol group, the difference failed to reach statistical sig-
nificance at the predetermined level of probability of
less than .05. Use of a leukocyte-depleting filter failed
to significantly affect cerebral and renal recovery after
DHCA in the neonatal piglet model used in the current
study. Accumulation of neutrophils in ischemic cere-
bral tissue, however, and the subsequent damaging
effects of neutrophil activation continue for many hours
after reperfusion. Neurobehavioral and histologic stud-
ies in survival models of DHCA will be necessary to
determine these longer-term effects.
We thank Dr Lawrence H Muhlbaier, PhD, for the statisti-
cal analysis of the study and Ronnie Johnson for his expert
technical help with the experiments. 
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